Encrypted RNA™ Programs

About Autonomous Therapeutics

Autonomous Therapeutics is a private, preclinical-stage biotech founded in 2016 and headquartered in Cambridge, MA, with a major R&D facility in Rockville, MD. The company is developing a novel class of 'Encrypted RNA' therapeutics designed to be activated only in target cells and to overcome resistance mechanisms, addressing a broad range of diseases. It has secured significant non-dilutive and venture funding from prestigious government agencies and investors, including DARPA, NIH, BARDA, and Third Kind Venture Capital, validating its innovative platform technology.

Therapeutic Areas